* Information available to verified or subscribed users. The first stage in this process is to Register - please
click here to Register.
If you have already Registered, please click here to login.
|
| Phrase | Consultant | Town | Special Interests |
| acute leukaemia | *Consultant(s)* | *Towns* | Young adult and adolescent haematology, acute leukaemia, chronic myeloid leukaemia |
| acute lymphoblastic leukaemia | *Consultant(s)* | *Towns* | AML - acute myeloid leukaemia, acute lymphoblastic leukaemia, paediatric haematology |
| Acute myeloid leukaemia | *Consultant(s)* | *Towns* | Acute myeloid leukaemia |
| AML - acute myeloid leukaemia | *Consultant(s)* | *Towns* | AML - acute myeloid leukaemia, acute lymphoblastic leukaemia, paediatric haematology |
| childhood leukaemia | *Consultant(s)* | *Towns* | Paediatric haematology, childhood leukaemia |
| chronic lymphatic leukaemia | *Consultant(s)* | *Towns* | Haematological oncology, chronic lymphatic leukaemia |
| chronic lymphocytic leukaemia | *Consultant(s)* | *Towns* | Lymphoma, chronic lymphocytic leukaemia, medical education |
| chronic myeloid leukaemia | *Consultant(s)* | *Towns* | Myeloproliferative disorders, chronic myeloid leukaemia, leukaemia, anaemia, abnormal blood counts, anticoagulation |
| chronic myeloid leukaemia | *Consultant(s)* | *Towns* | Young adult and adolescent haematology, acute leukaemia, chronic myeloid leukaemia |
| epigenetic targeting of chronic lymphocytic leukaemia | *Consultant(s)* | *Towns* | Haematological malignancies, epigenetic targeting of chronic lymphocytic leukaemia |
| including acute leukaemia | *Consultant(s)* | *Towns* | Malignant haematology, including acute leukaemia, myeloma, lymphoma, myelodysplastic syndromes - MDS, myeloproliferative neoplasms - MPN, including diagnosis, treatment complications, and outcomes, haemostasis and thrombosis, including venous thromboembolism (DVT, pulmonary embolism), arterial thrombosis (including stroke), and anticoagulation management (warfarin, heparin, and direct oral anticoagulants), including complications and errors, haemoglobinopathies, including sickle cell disease and thalassaemia, including complications and management, transfusion medicine, including transfusion reactions, compatibility issues, and delays in transfusion, bleeding disorders, including haemophilia, von Willebrand's disease, and platelet disorders, general and diagnostic haematology, including investigation of anaemia, cytopenias, abnormal blood results and delayed or missed diagnosis |
| leukaemia | *Consultant(s)* | *Towns* | Haematological oncology, leukaemia, lymphoma, stem cell therapy, non-Hodgkin's lymphoma, Hodgkin's disease, myelodysplastic syndromes - MDS |
| leukaemia | *Consultant(s)* | *Towns* | Myeloproliferative disorders, chronic myeloid leukaemia, leukaemia, anaemia, abnormal blood counts, anticoagulation |
| Leukaemia | *Consultant(s)* | *Towns* | Leukaemia |
|
|
|
|
